Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Augmedix, Inc. provides remote medical documentation solutions and live clinical support services in the United States. Its platform offers Augmedix Live that provides synchronous medical note documentation and point of care support; Augmedix Go Assist that offers asynchronous medical documentation based upon previously recorded visits; Augmedix Prep that provides patient demographics, past medical history, medication changes and other points from the patient's health record; and Augmedix Go, an autonomous, ambient AI mobile software application that offers fully automated medical documentation based upon recorded visits. The company enables clinicians to access its applications through mobile devices, such as smartphones. It serves health systems and specialty groups. The company was formerly known as Malo Holdings Corporation and changed its name to Augmedix, Inc. in October 2020. The company was founded in 2013 and is headquartered in San Francisco, California. more
Time Frame | AUGX | Sector | S&P500 |
---|
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | 5YR TREND | |
---|---|---|---|---|---|---|
Total Revenue | 14.11M | 16.48M | 22.16M | 30.93M | 44.85M | [{"date":"2019-12-31","value":31.45,"profit":true},{"date":"2020-12-31","value":36.75,"profit":true},{"date":"2021-12-31","value":49.41,"profit":true},{"date":"2022-12-31","value":68.96,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Cost of Revenue | 9.43M | 9.69M | 12.16M | 16.98M | 23.33M | [{"date":"2019-12-31","value":40.42,"profit":true},{"date":"2020-12-31","value":41.53,"profit":true},{"date":"2021-12-31","value":52.12,"profit":true},{"date":"2022-12-31","value":72.78,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Gross Profit | 4.68M | 6.79M | 10.01M | 13.95M | 21.53M | [{"date":"2019-12-31","value":21.74,"profit":true},{"date":"2020-12-31","value":31.56,"profit":true},{"date":"2021-12-31","value":46.49,"profit":true},{"date":"2022-12-31","value":64.82,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Gross Margin | 33.17% | 41.22% | 45.15% | 45.11% | 47.99% | [{"date":"2019-12-31","value":69.11,"profit":true},{"date":"2020-12-31","value":85.89,"profit":true},{"date":"2021-12-31","value":94.08,"profit":true},{"date":"2022-12-31","value":94,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Operating Expenses | 21.42M | 20.49M | 27.95M | 36.33M | 40.30M | [{"date":"2019-12-31","value":53.15,"profit":true},{"date":"2020-12-31","value":50.83,"profit":true},{"date":"2021-12-31","value":69.33,"profit":true},{"date":"2022-12-31","value":90.13,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Operating Income | (16.74M) | (13.69M) | (17.94M) | (22.37M) | (18.78M) | [{"date":"2019-12-31","value":-1674270900,"profit":false},{"date":"2020-12-31","value":-1369300000,"profit":false},{"date":"2021-12-31","value":-1793800000,"profit":false},{"date":"2022-12-31","value":-2237100000,"profit":false},{"date":"2023-12-31","value":-1877900000,"profit":false}] |
Total Non-Operating Income/Expense | (4.56M) | (3.35M) | (2.40M) | (3.51M) | (1.32M) | [{"date":"2019-12-31","value":-456172500,"profit":false},{"date":"2020-12-31","value":-335318700,"profit":false},{"date":"2021-12-31","value":-239600000,"profit":false},{"date":"2022-12-31","value":-350800000,"profit":false},{"date":"2023-12-31","value":-132500000,"profit":false}] |
Pre-Tax Income | (18.50M) | (15.60M) | (17.85M) | (24.45M) | (19.03M) | [{"date":"2019-12-31","value":-1849834100,"profit":false},{"date":"2020-12-31","value":-1560400000,"profit":false},{"date":"2021-12-31","value":-1785100000,"profit":false},{"date":"2022-12-31","value":-2444900000,"profit":false},{"date":"2023-12-31","value":-1902600000,"profit":false}] |
Income Taxes | 3.86M | (867.00K) | (691.00K) | 2.08M | 145.00K | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":-22.44,"profit":false},{"date":"2021-12-31","value":-17.89,"profit":false},{"date":"2022-12-31","value":53.79,"profit":true},{"date":"2023-12-31","value":3.75,"profit":true}] |
Income After Taxes | (22.36M) | (14.74M) | (17.16M) | (26.53M) | (19.17M) | [{"date":"2019-12-31","value":-2236116300,"profit":false},{"date":"2020-12-31","value":-1473700000,"profit":false},{"date":"2021-12-31","value":-1716000000,"profit":false},{"date":"2022-12-31","value":-2652700000,"profit":false},{"date":"2023-12-31","value":-1917100000,"profit":false}] |
Income From Continuous Operations | (18.50M) | (15.60M) | (17.85M) | (24.45M) | (20.28M) | [{"date":"2019-12-31","value":-1849834100,"profit":false},{"date":"2020-12-31","value":-1560371600,"profit":false},{"date":"2021-12-31","value":-1785100000,"profit":false},{"date":"2022-12-31","value":-2444900000,"profit":false},{"date":"2023-12-31","value":-2027800000,"profit":false}] |
Income From Discontinued Operations | - | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Net Income | (22.36M) | (14.74M) | (17.16M) | (26.53M) | (19.17M) | [{"date":"2019-12-31","value":-2236116300,"profit":false},{"date":"2020-12-31","value":-1473700000,"profit":false},{"date":"2021-12-31","value":-1716000000,"profit":false},{"date":"2022-12-31","value":-2652700000,"profit":false},{"date":"2023-12-31","value":-1917100000,"profit":false}] |
EPS (Diluted) | (12.96) | (4.33) | (0.69) | (0.69) | (0.45) | [{"date":"2019-12-31","value":-1295.6,"profit":false},{"date":"2020-12-31","value":-433.3,"profit":false},{"date":"2021-12-31","value":-69,"profit":false},{"date":"2022-12-31","value":-69,"profit":false},{"date":"2023-12-31","value":-45,"profit":false}] |
These ratios help you determine the liquidity of the company. Higher is better.
AUGX | |
---|---|
Cash Ratio | 1.18 |
Current Ratio | 1.66 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
AUGX | |
---|---|
ROA (LTM) | -30.61% |
ROE (LTM) | -329.78% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
AUGX | |
---|---|
Debt Ratio Lower is generally better. Negative is bad. | 0.80 |
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.20 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
AUGX | |
---|---|
Trailing PE | NM |
Forward PE | NM |
P/S (TTM) | 2.25 |
P/B | 11.09 |
Price/FCF | NM |
EV/R | 2.19 |
EV/Ebitda | NM |
Augmedix Inc (AUGX) share price today is $
Yes, Indians can buy shares of Augmedix Inc (AUGX) on Vested. To buy Augmedix Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in AUGX stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of Augmedix Inc (AUGX) via the Vested app. You can start investing in Augmedix Inc (AUGX) with a minimum investment of $1.
You can invest in shares of Augmedix Inc (AUGX) via Vested in three simple steps:
The 52-week high price of Augmedix Inc (AUGX) is $5.16. The 52-week low price of Augmedix Inc (AUGX) is $0.73.
The price-to-earnings (P/E) ratio of Augmedix Inc (AUGX) is
The price-to-book (P/B) ratio of Augmedix Inc (AUGX) is 11.09
The dividend yield of Augmedix Inc (AUGX) is 0.00%
The market capitalization of Augmedix Inc (AUGX) is $116.16M
The stock symbol (or ticker) of Augmedix Inc is AUGX